Before administering lithium to a patient, it is most important for the nurse to assess which laboratory value?

Choice A rationale Lithium is a mood stabilizer primarily used in the treatment of bipolar disorder. Its therapeutic and toxic effects are not directly related to blood sugar regulation. While some antipsychotics can impact glucose metabolism, lithium's mechanism of action does not involve insulin or glucagon pathways. Therefore, blood sugar assessment is not the most critical lab value prior to administration. Choice B rationale Lithium is a monovalent cation that competes with sodium for renal reabsorption. When sodium levels are low, the kidneys reabsorb more lithium to compensate, increasing the risk of lithium toxicity. Conversely, high sodium can increase lithium excretion. Therefore, assessing a patient's serum sodium level (normal range: 135-145 mEq/L) is crucial to prevent lithium accumulation and subsequent toxicity. Choice C rationale While urine osmolality can be affected by lithium's long-term effects on the kidneys, such as nephrogenic diabetes insipidus, it is not the most crucial parameter to assess before starting therapy. The primary and immediate risk is related to the competition between lithium and sodium for reabsorption, which directly influences serum lithium levels and the risk of toxicity, making sodium assessment paramount. Choice D rationale Hematocrit measures the proportion of red blood cells in the blood and is not directly influenced by lithium. While long-term lithium use can affect other blood cell lines, such as leukocytes, hematocrit is not a primary safety concern or a pre-administration requirement. The most critical lab value for lithium safety is its close relationship with sodium and renal function.